Abstract
A chimeric receptor (130/190) containing the cytoplasmic region of leukemia inhibitory factor receptor α subunit (LIFRα, or gp190) and the extracellular transmembrane region of gp130 was generated. Expressed of the 130/190 chimera in HL-60 cells to induced the homodimerization of the cytoplasmic domains (190cyt-190cyt) with whole LIFRα subunit on HL-60 cells in response to LIF. Expression and activation of the signal transducer and activator of transcription factor-3 (Stat3) and inhibition of leukemia cell proliferation were evaluated in cells transfected with this chimeric molecule. Increased tyrosyl phosphorylation of Stat3 at Tyr705 was detected after 10 min LIF treatment in cells transfected with either the 130/190 or the wild type receptor. Cell proliferation was decreased upon LIF treatment in both cell types. However, expression of the C-terminal region of the cytoplasmic region of LIFRα subunit (190CT) in HL-60 cells resulted in lower levels of Stat3 phosphorylation induction by LIF and cell proliferation was unaffected. Immunohistochemical staining indicated an inverse correlation between Cdc25B expression and the levels of phospho-Stat3 in 190CT and 130/190 cells. Expression of CD15, a cell differentiation marker, was lower in 190CT than in 130/190 cells. Together, these results suggest that homodimerization of the 190 cytoplasmic region promotes the Tyr 705 phosphorylation, which correlates with the inhibition of proliferation and stimulation of differentiation in HL-60 cells. Our results also suggest a signal link between Stat3 and Cdc25B.
Similar content being viewed by others
References
Hilton DJ: LIF: Lots of interesting functions. Trends Biochem Sci 17: 73–76, 1992
Gearing DP, Comeau NR, Friend DJ, Gimpel SD, Thut CJ, McGourty J, Brasher KK, King JA, Gillis S, Mosley B: The IL-6 signal transducer, gp130: An oncostatin M receptor and affinity converter for the LIF receptor. Science 255: 1434–1437, 1992
Ip NY, Nye SH, Boulton TG, Davis S, Taga T, Li Y, Birren SJ, Yasukawa K, Kishimoto T, Anderson DJ: CNTF and LIF act on neuronal cell via shared signaling pathways that involve the IL-6 signal transducing receptor component gp130. Cell 69: 1121–1132, 1992
Gearing DP, Thut CJ, Vande BT, Gimpel SD, Delaney PB, King J, Price V, Cosman D, Beckmann MP: Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp130. EMBO J 10: 2839–2848, 1991
Rao MS, Symes A, Malik N, Shoyab M, Fink JS, Landis SC: Oncostatin M regulates VIP expression in a human neuroblastoma cell line. Neuroreport 3: 865–868, 1992
Taga T, Narazaki M, Yasukawa K, Saito T, Miki D, Hamaguchi M, Davis S, Shoyab M, Yancopoulos GD, Kishimoto T: Functional inhibition of hematopoietic and neurotrophic cytokines by blocking the IL-6 signal transducer gp130. Proc Natl Acad Sci USA 89: 10998–11001, 1992
Zhong Z, Wen Z, Darnell JE: Stat3: A STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 264: 95–98, 1994
Lai C-F, Ripperger J, Morella KK, Wang Y, Gearing DP, Fey GH, Baumann H: Separate signaling mechanisms are involved in the control of STAT protein activation and gene regulation via the interleukin 6 response element by the box 3 motif of gp130. J Biol Chem 270: 14847–14850, 1995
Baumann H, Ziegler SF, Mosley B, Morella KK, Pajovic S, Gearing DP: Reconstitution of the response to leukemia inhibitory factor, oncostatin M and ciliary neurotrophic factor in hepatoma cells. J Biol Chem 268: 8414–8417, 1993
Yamanaka Y, Nakajima K, Fukada T, Hibi M, Hirano T: Differentiation and growth arrest signals are generated through the cytoplasmic region of gp130 that is essential for Stat3 activation. EMBO J 15: 1557–1565, 1996
Murakami M, Narazaki M, Hibi M, Yawata H, Yasukawa K, Hamaguchi M, Taga T, Kishimoto T: Critical cytoplasmic region of the interleukin-6 signal transducer gp130 is conserved in the cytokine receptor family. Proc Natl Acad Sci USA, 88: 11349–11353, 1991
Stahl N, Boulton TG, Farruggella T, Ip NY, Davis S, Witthuhn BA, Quelle FW, Silvennoinen O, Barbieri G, Pellegrini S: Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta-receptor components. Science 263: 92–95, 1994
Argetsinger LS, Campbell GS, Yang X, Witthuhn BA, Silvennoinen O, Ihle JN, Carter-Su C: Identification of JA-K2 as a growth hormone receptor-associated tyrosine kinase. Cell 74: 237–244, 1993
Baumann H, Symes AJ, Comeau NM, Morella KK, Wang Y, Friend D, Ziegler SF, Fink JS, Gearing DP: Multiple regions within the cytoplasmic domains of the leukemia inhibitory factor and gp130 cooperate in signal transduction in hepatic and neuronal cells. Mol Cell Biol 14: 138–146, 1994
Schiemann WP, Bartoe JL, Nathanson NM: Box3-independent signal mechanisms are involved in leukemia inhibitory factor receptor α and gp130-mediated stimulation of mitogen-activated kinase. J Biol Chem 272: 16631–16636, 1997
Stahl N, Fan-uggella TJ, Boulton TG, Zhong Z, Darnell JE Jr, Yancopoulos GD: Choice of STATS and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science 267: 1349–1353, 1995
Schiemann WP, Graves LM, Baumann H, Morella KK, Gearing DP, Nielsen MD, Krebs EG, Nathanson NM: Phosphorylation of the human leukemia inhibitory factor (LIF) receptor by mitogen-activated protein kinase and the regulation of LIF receptor function by heterologous receptor activation. Proc Natl Acad Sci USA 92: 5361–5365, 1995
Starr R, Novak U, Willson TA, Inglese M, Murphy V, Alexander WS, Metcalf D, Nicola NA, Hilton DJ, Ernst M: Distinct roles for leukemia inhibitory factor α chain and gp130 in cell type-specific signal transduction. J Biol Chem 272: 19982–19986, 1997
Minami M, Inoue M, Wei S, Takeda K, Matsumoto M, Kishimoto T, Akira S: STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line. Proc Natl Acad Sci USA 93: 3963–3966, 1996
Kiuchi N, Nakajima K, Ichiba M, Fukada T, Narimatsu M, Mizuno K, Hibi M, Hirano T: STAT3 is required for the gp130-mediated full activation of the c-myc gene. J Exp Med 189: 63–73, 1999
Tomida MI, Heike T, Yokota T: Cytoplasmic domains of the leukemia inhibitory factor receptor required for STAT3 activation, differentiation, and growth arrest of myeloid leukemic cells. Blood 93: 1934–1941, 1999
Galaktionov K, Beach D: Specific activation of Cdc25 tyrosine phosphatases by B-type cyclins: Evidence for multiple roles of mitotic cyclins. Cell 67: 1181–1194, 1991
Nilsson I, Hoffmann I: Cell cycle regulation by the Cdc25 phosphatase family. Prog Cell Cycle Res 4: 107–114, 2000
Liu HQ, Shan JK, Tang SP: Involving of the cytoplasmic domain of leukemia inhibitory factor (LIF) receptor α subunit, IL-6 related signal transducer-gp130 or Fas death domain for MAPK p42/44 activation in HL-60 cell with LIF or anti-Fas IgG. Mol Cell Biochem 217: 113–120, 2001
Zhu K, Liu HQ, Liu XP, Fu JL: Cloning and expression of leukemia inhibitory factor in CHO cell line and its inhibitory effect on the proliferation of U937. J Exp Hematology 6: 190–193, 1998
Maekawa T, Metcalf D: Colonial suppression of HL-60 and U937 cells by recombinant leukemia inhibitory factor in combination with GMCSF or G-CSF. Leukemia 3: 270–276, 1989
Gough NM, Williams RL: The pleiotropic actions of leukemia inhibitory factor. Cancer Cell 1: 77–80, 1989
Nakajima K, Yamanaka Y, Nakae K, Kojima H, Ichiba M, Kiuchi N, Kitaoka T, Fukada T, Hibi M, Hirano T: A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells. EMBO J 15: 3651–3658, 1996
Senga T, Iwamoto T, Kitamura T, Miyake Y, Hamaguchi M: JAK/STAT3-dependent activation of the RalGDS/Ral pathway in M1 mouse myeloid leukemia cells. J Biol Chem 276: 32678–32681, 2001
Tomida M: Structural and functional studies on the leukemia inhibitory factor receptor (lif-r): Gene and soluble form of lif-r, and cytoplasmic domain of lif-r required for differentiation and growth arrest of myeloid leukemic cells. Leuk Lymphoma 37:517–525, 2000
Hermanns HM, Radtke S, Haan C, Schmitz-Van de Leur H, Tavernier J, Heinrich PC, Behrmann I: Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130. J Immunol 163: 6651–6658, 1999
Zhang JG, Zhang Y, Owczarek CM, Ward LD, Moritz RL, Simpson RJ, Yasukawa K, Nicola NA: Identification and characterization of two distinct truncated forms of gp130 and a soluble form of leukemia inhibitory factor receptor alpha-chain in normal human urine and plasma. J Biol Chem 273: 10798–10805, 1998
Layton MJ, Cross BA, Metcalf D, Ward LD, Simpson RJ, Nicola NA: A major binding protein for leukemia inhibitory factor in normal mouse serum: Identification as a soluble form of the cellular receptor. Proc Natl Acad Sci USA 89: 8616–8620, 1992
Yamaguchi-Yamamoto Y, Tomida M, Hozumi M: Pregnancy associated increase in differentiation-stimulating factor (D-factor)/leukemia inhibitory factor (LIF)-binding substance(s) in mouse serum. Leuk Res 17: 515–522, 1993
Schaeffer M, Schneiderbauer M, Weidler S, Tavares R, Warmuth M, de Vos G, Hallek M: Signaling through a novel domain of gp130 mediates cell proliferation and activation of Hck and Erk kinases. Mol Cell Biol 21: 8068–8081, 2001
Kimura T, Sakabe H, Minamiguchi H, Fujiki H, Abe T, Kaneko H, Yokota S, Nakagawa H, Fujii H, Tamaki H, Ogawa H, Sugiyama H, Sonoda Y: Interleukin-11 (IL-11) enhances clonal proliferation of acute myelogenous leukemia cells with strong expression of the IL-11 receptor alpha chain and signal transducing gp130. Leukemia 13: 1018–1027, 1999
Shirogane T, Fukada T, Muller JM, Shima DT, Hibi M, Hirano T: Synergistic roles for Pim-I and c-Myc in STAT3-mediated cell cycle progression and antiapoptosis. Immunity 111: 709–719, 1999
Smithgall TE, Briggs SD, Schreiner S, Lerner EC, Cheng H, Wilson MB: Control of myeloid differentiation and survival by Stats. Oncogene 19: 2612–2618, 2000
Hirano T, Ishihara K, Hibi M: Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene 19: 2548–2556, 2000
Goldstone S, Pavey S, Forrest A, Sinnamon J, Gabrielli B: Cdc25-dependent activation of cyclin A/cdk2 is blocked in G2 phase arrested cells independently of ATM/ATR. Oncogene 20: 921–932, 2001
Lammer C, Wagerer S, Saffrich R, Mertens D, Ansorge W, Hoffmann I: The cdc25B phosphatase is essential for the G2/M phase transition in human cells. J Cell Sci 111: 2445–2453, 1998
Blanchard F, Duplomb L, Wang Y, Robledo O, Kinzie E, Pitard V, Godard A, Jacques Y, Baumann H: Stimulation of leukemia inhibitory factor receptor degradation by extracellular signal-regulated kinase. J Biol Chem 275: 28793–28801, 2000
Anhuf D, Weissenbach M, Schmitz J, Sobota R, Hermanns HM, Radtke S, Linnemann S, Behrmann I, Heinrich PC, Schaper F: Signal transduction of IL-6, leukemia-inhibitory factor, and oncostatin M: Structural receptor requirements for signal attenuation. J Immunol 165: 2535–43, 2000
Hanjan SN, Kearney JF, Cooper MD: A monoclonal antibody (MMA) that identifies a differentiation antigen on human myelomonocytic cells. Clin Immunol Immunopathol 23: 172–188, 1982
Civin CL, Mirro J, Banquerigo ML: My-1, new myeloid-specific antigens identified by a mouse monoclonal antibody. Blood 57: 842–845, 1981
Devitt A, Moffatt OD, Raykundalia C, Capra JD, Simmons DL, Gregory CD: Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature 392: 505–509, 1998
Mills KI, Woodgate LJ, Gilkes AF, Walsh V, Sweeney MC, Brown G, Burnett AK: Inhibition of mitochondrial function in HL-60 cells is associated with an increased apoptosis and expression of CD14. Biochem Biophys Res Commun 263: 294–300, 1999
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Liu, H., Liu, S., Tang, S. et al. Molecular analysis of signaling events mediated by the cytoplasmic domain of leukemia inhibitory factor receptor α subunit. Mol Cell Biochem 258, 15–23 (2004). https://doi.org/10.1023/B:MCBI.0000012829.10405.e1
Issue Date:
DOI: https://doi.org/10.1023/B:MCBI.0000012829.10405.e1